The governing board of the California
stem cell agency is hearing a
presentation on pediatric heart disease by Deepak
Srivastava of the Gladstone Institutes. The formal meeting is
scheduled to resume following the presentation. However, there does
not appear to be any major business remaining on the agenda.
Nonetheless, the California Stem Cell Report will
continue to monitor the meeting for any developments worthy of note.
No comments:
Post a Comment